Kevin Donovan

Irish (born 1959), has been a board member of Cosmo Pharmaceuticals NV since March 2016.

Kevin Donovan is a Fellow of the Institute of Chartered Accountants in Ireland and a member of the Institute of Directors. Kevin Donovan graduated from University College Dublin with a Bachelor of Commerce Degree and worked with PWC in Dublin for four years before transferring to PWC in Boston for a further three years. He was a founding shareholder and director of Sentinel Investments, where he developed a substantial portfolio of international aircraft leasing business, before selling his interest in Sentinel in 2006.

Kevin Donovan has also been a partner in FGS Chartered Accountants in Dublin (now Grant Thornton) and has held a number of board positions with foreign corporations setting up operations in Ireland in a variety of industries including aviation, pharmaceuticals, biotechnology and oil exploration. He is currently active in international property investment and manages a substantial property portfolio in Berlin.